Safety Outcomes When “Switching” Between Biosimilars and Reference Products

Safety Outcomes When “Switching” Between Biosimilars and Reference Products

Source: FDA Center for Drug Evaluation and Research - What's New - February 27, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news